14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Jan 30, 2026
MNMD vs MPW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Jan 30, 2026, Medical Properties Trust, Inc. (MPW) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MNMD carries a Unified Composite Score of 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin), whereas MPW carries 52.6/100 (HOLD) at $5.02 (6.7x Forward P/E, 58.2% operating margin).
Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. MPW 52.6/100 HOLD), MPW captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (58.2% vs. 0.0% operating margin) and revenue trajectory (+9.9% vs. +0.0% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MNMD vs MPW. Trailing 12-month operating profitability (MNMD 0.0% vs MPW 58.2%) and valuation multiples (MNMD N/M vs MPW 6.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $1.4B market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
MPW Moat ProfileHigh-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.0B market capitalization and 58.2% operating margin.
OpEx & R&D Reinvestment38.2% of Rev ($385M)
90D Engineering Disclosures0 Published
Investor FAQ MNMD vs MPW Key Questions & Quantitative Answers
As of Jan 30, 2026, Medical Properties Trust, Inc. (MPW) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MNMD carries a Unified Composite Score of 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin), whereas MPW carries 52.6/100 (HOLD) at $5.02 (6.7x Forward P/E, 58.2% operating margin). Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. MPW 52.6/100 HOLD), MPW captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (58.2% vs. 0.0% operating margin) and revenue trajectory (+9.9% vs. +0.0% YoY).
MPW leads the Growth & Scale pillar: MNMD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with MPW at +9.9% YoY revenue growth and -48.6% YoY earnings growth on $1.01B TTM revenue (96.4% gross margin, 58.2% operating margin). On trailing 12-month operating scale, MNMD generates N/A in USD-normalized revenue versus $1.01B for MPW. In operating R&D and SG&A reinvestment, MNMD deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($385M) (0 disclosures) for MPW.
MPW screens cheaper on headline valuation multiples. MNMD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MPW trades at 6.7x Forward P/E, 6.7x Trailing P/E, 1.93x PEG, and 3.0x EV/Revenue (81.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MNMD (-85.6% ROE) versus MPW (-14.0% ROE) capital efficiency.
In options market volatility and institutional positioning, MNMD carries 70.7% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.18x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.79β · 55% Vol realized risk). By comparison, MPW carries 24.3% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 26% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jan 30, 2026. For educational research only; not investment advice.